AgomAb Share Price
NASDAQ: AGMB | OthersAgomAb Stock Performance
AgomAb Share Price Today
As of 19 November 2026, AgomAb Therapeutics NV's share price is $5.76. The stock opened at $6.16, compared to its previous close of $5.98. During today's trading session, AgomAb Therapeutics NV's share price traded between $5.74 and $6.19, with an average price of $5.96. Over the past 52 weeks, the stock has recorded a high of $17.39 and a low of $5.58. In terms of performance, AgomAb Therapeutics NV's share price has declined by 49.85% over the last six months and is down 64.07% on a year-on-year basis.
AgomAb Share Price Chart
About AgomAb
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
AgomAb Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $7.52 | $5.74 | -20.57% |
Oct 2026 | $11.01 | $7.22 | -34.84% |
Sep 2026 | $12.92 | $11.08 | -20.17% |
Aug 2026 | $12.70 | $13.88 | +10.42% |
Jul 2026 | $12.98 | $12.57 | -4.77% |
Jun 2026 | $11.17 | $13.20 | +14.93% |
May 2026 | $11.06 | $11.48 | +6.44% |
Apr 2026 | $11.20 | $10.79 | +1.27% |
Mar 2026 | $16.10 | $10.65 | -33.53% |
Feb 2026 | $14.30 | $16.03 | N/A |